ALK expressing desmoid fibromatosis treated with Crizotinib: a clinical case
Forum of Clinical Oncology · 14.07.2026
DOI: 10.2478/fco-2024-0028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Forum of Clinical Oncology, online erschienen am 14.07.2026. Verfasst von Polina Eduardovna Kopylova und 5 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Desmoid fibromatosis (DF) is a rare myofibroblastic neoplasm with invasive growth and a tendency to local recurrence. A number of patients have been found to suffer from relapse after surgical treatment. Moreover, there are several instances where the DF treated with radiotherapy led to radio-induced sarcoma. Here in our practice, we have revealed that DF can express ALK and adjuvant therapy with Crizotinib is possible after the surgical treatment. Case presentation A young patient was initially diagnosed with DF in the projection of the right shoulder. Initially, the tumour mass was left under strict active surveillance. When the tumour grew aggressively after two years, the patient underwent an interscapulothoracic amputation of the right upper limb followed by targeted adjuvant therapy with Crizotinib. The patient is relapse free for five years.
Conclusion
DF has been found to have a tendency to local recurrence. Furthermore, radiation therapy has a risk of inadvertently transforming the tumour into sarcoma. Here, we have demonstrated that such patients can be checked for ALK mutation, and an adjuvant therapy with Crizotinib can be recommended.
Zitieren
APA
Kopylova, P. E., Ranjit, R., Yadrina, A. V., Derzhavin, V. A., Bukharov, A. V., & Aliev, M. J. (2026). ALK expressing desmoid fibromatosis treated with Crizotinib: a clinical case. Forum of Clinical Oncology. https://doi.org/10.2478/fco-2024-0028
Vancouver
Kopylova PE, Ranjit R, Yadrina AV, Derzhavin VA, Bukharov AV, Aliev MJ. ALK expressing desmoid fibromatosis treated with Crizotinib: a clinical case. Forum of Clinical Oncology. 2026. doi:10.2478/fco-2024-0028
BibTeX
@article{Kopylova2026,
author = {Kopylova, Polina Eduardovna and Ranjit, Rajesh and Yadrina, Anna Viktorovna and Derzhavin, Vitaly Andreevich and Bukharov, Artem Viktorovich and Aliev, Mamed Javadovich},
title = {ALK expressing desmoid fibromatosis treated with Crizotinib: a clinical case},
journal = {Forum of Clinical Oncology},
year = {2026},
doi = {10.2478/fco-2024-0028}
}
EUVIMED